B1371003 (#475)
Laufzeit: 01.01.2013 - 31.12.2019
imported
Kurzfassung
PF-04449913 in combination with chemotherapy is indicated for the treatment of previously untreated acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS).
